Further characterization of the Sho-saiko-to-mediated antitumor effect on melanoma developed in RET-transgenic mice [1]

Journal of Investigative Dermatology

Volumn 114, Issue 3, 2000, Pages 599-601

  Karo, M ^a   Isobe, K I ^a   Dai, Y ^a   Liu, W ^a   Takahashi, M ^a   Nakashima, I ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN; PROTEIN RET; UNCLASSIFIED DRUG; XIAO CHAI HU TANG; ANTINEOPLASTIC AGENT; HERBACEOUS AGENT; SAIKO-KEISHI-TO; SHOSAIKOTO GO KEISHIKASHAKUYAKUTO;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; CONTROLLED STUDY; HERBAL MEDICINE; IMMUNOPATHOLOGY; LETTER; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; ANIMAL;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUGS, CHINESE HERBAL; MELANOMA; MICE; MICE, TRANSGENIC;

EID: 0033624870     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2000.02005.x     Document Type: Letter

References (6)

1. M. Ichihara T. Iwamoto K. Isobe Oncogene-linked in situ immunotherapy of pre-B lymphoma arising in Eμ/ret transgenic mice Br J Cancer 71 1995 808 813
2. T. Iwamoto M. Pu M. Ito Preferential development of pre-B lymphomas with drastically down-regulated N-myc in the Eμ-ret transgenic mice Eur J Immunol 21 1991 1809 1814
3. M. Kato W. Liu H. Yi The herbal medicine Sho-saiko-to inhibits growth and metastasis of malignant melanoma primarily developed in ret -transgenic mice J Invest Dermatol 111 1998 640 644
4. M. Kato M. Takahashi A.A. Akhand Transgenic mouse model for skin malignant melanoma Oncogene 17 1998 1885 1888
5. M. Kato W. Liu A.A. Akhand Linkage between melanocytic tumor development and early burst of Ret protein expression for tolerance induction in metallothionein-I/ret transgenic mouse lines Oncogene 18 1999 837 842
6. F. Trautinger I. Kindas-Mugge B. Barlan P. Neuner R.M. Knobler 72-kD heat shock protein is a mediator of resistance to ultraviolet B light J Invest Dermatol 105 1995 160 162